BCS Private Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.48M Buy
10,915
+860
+9% +$413K 1.65% 16
2026
Q1
$4.95M Sell
10,055
-196
-2% -$106K 1.5% 16
2025
Q4
$5.94M Sell
10,251
-590
-5% -$334K 2.03% 11
2025
Q3
$5.26M Buy
10,841
+215
+2% +$100K 1.88% 13
2025
Q2
$4.31M Buy
+10,626
New +$4.44M 1.62% 16

Other funds holding TMO

BCS Private Wealth Management's TMO Position: Q2 2026 in Review

BCS Private Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 8.6% in Q2 2026, buying an estimated $413K and bringing the position to 10,915 shares worth $5.48M. The position accounts for 1.65% of the portfolio, ranked #16.

BCS Private Wealth Management first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.94M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • BCS Private Wealth Management held 10,915 shares of Thermo Fisher Scientific worth $5.48M as of Q2 2026.
  • BCS Private Wealth Management bought 860 Thermo Fisher Scientific shares in Q2 2026, an estimated $413K.
  • Thermo Fisher Scientific made up 1.65% of BCS Private Wealth Management's portfolio in Q2 2026, its #16 holding.
  • BCS Private Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • BCS Private Wealth Management's Thermo Fisher Scientific position peaked at $5.94M in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on BCS Private Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.